Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -7.24 |
| peg ratio | 0.99 |
| price to book ratio | -18.11 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -0.66 |
| price fair value | -18.11 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -142.62% |
| return on equity | 275.85% |
| return on capital employed | 493.77% |
liquidity ratio | |
|---|---|
| current ratio | 0.39 |
| quick ratio | 0.39 |
| cash ratio | 0.36 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 4,185.46 |
| cash conversion cycle | -4,185.46 |
| receivables turnover | 0.00 |
| payables turnover | 0.09 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.28 |
| debt equity ratio | -0.49 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.95 |
| interest coverage | -543.93 |
| cash flow to debt ratio | -5.61 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.20 |
| cash per share | 0.07 |
| operating cash flow per share | -0.20 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -5.61 |
| short term coverage ratios | -98.97 |
| capital expenditure coverage ratio | -2,530,548.25 |
Frequently Asked Questions
When was the last time CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) reported earnings?
CERo Therapeutics Holdings, Inc. (CERO) published its most recent earnings results on 20-11-2024.
What is CERo Therapeutics Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. CERo Therapeutics Holdings, Inc. (NASDAQ:CERO)'s trailing twelve months ROE is 275.85%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. CERo Therapeutics Holdings, Inc. (CERO) currently has a ROA of -142.62%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CERO's net profit margin stand at?
CERO reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CERO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.39 in the most recent quarter. The quick ratio stood at 0.39, with a Debt/Eq ratio of -0.49.